Medicare Enrolled
Dr. Shayhira Suazo Herrera, MD
Endocrinology · Cape Coral, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Suazo Herrera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Suazo Herrera?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Suazo Herrera
Dr. Shayhira Suazo Herrera is an endocrinology specialist in Cape Coral, FL, with 14 years of NPI registration. Based on federal Medicare data, Dr. Suazo Herrera performed 4,656 Medicare services across 2,625 unique beneficiaries.
Between the years covered by Open Payments, Dr. Suazo Herrera received a total of $16,145 from 54 pharmaceutical and/or device companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Suazo Herrera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 13% volume in FL
$16,145 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 150486 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗4,656
Medicare services
Top 13% in FL for endocrinology
2,625
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~333 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
820 | $94 | $264 |
| Denosumab injection (Prolia/Xgeva) | 661 | $18 | $46 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
488 | $8 | $17 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
319 | $10 | $21 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
290 | $16 | $34 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
287 | $9 | $18 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
286 | $27 | $71 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
191 | $9 | $19 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
183 | $13 | $27 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
163 | $125 | $347 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
159 | $6 | $12 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
159 | $5 | $10 |
| Total T3 thyroid hormone test A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels. |
107 | $14 | $28 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
102 | $29 | $59 |
| New patient office visit, complex (60-74 min) | 64 | $164 | $459 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
61 | $14 | $30 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
59 | $40 | $83 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
54 | $115 | $370 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
45 | $17 | $34 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
38 | $7 | $16 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
32 | $108 | $296 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $73 | $187 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
20 | $9 | $29 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
15 | $16 | $33 |
| LDL cholesterol level test A blood test that measures the amount of low-density lipoprotein (LDL) cholesterol in your blood. LDL is often referred to as "bad" cholesterol. |
15 | $10 | $21 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
14 | $3 | $7 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,145
Total received (2018-2024)
Avg $2,306/year across 7 years
Top 21% in FL for endocrinology
54
Companies
316
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,608 (53.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,537 (46.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,869
2023
$2,159
2022
$2,026
2021
$4,261
2020
$4,325
2019
$535
2018
$970
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$8,131
AstraZeneca Pharmaceuticals LP
$869
SANOFI-AVENTIS U.S. LLC
$724
Novo Nordisk Inc
$619
GlaxoSmithKline, LLC.
$445
Medtronic, Inc.
$382
Xeris Pharmaceuticals, Inc.
$378
Amgen Inc.
$352
Alexion Pharmaceuticals, Inc.
$285
Bayer HealthCare Pharmaceuticals Inc.
$284
Abbott Laboratories
$260
Dexcom, Inc.
$259
Radius Health, Inc.
$240
Valeritas, Inc.
$238
Corcept Therapeutics
$223
Nevro Corp.
$209
Tandem Diabetes Care, Inc.
$172
United Therapeutics Corporation
$165
Novartis Pharmaceuticals Corporation
$157
Bayer Healthcare Pharmaceuticals Inc.
$156
Boehringer Ingelheim Pharmaceuticals, Inc.
$135
Zealand Pharma US, Inc.
$123
Janssen Pharmaceuticals, Inc
$94
Amneal Pharmaceuticals LLC
$89
Baxter Healthcare
$87
GRT US Holding, Inc.
$82
Kyowa Kirin, Inc.
$81
Grifols USA, LLC
$77
LIFESCAN, INC.
$73
GENZYME CORPORATION
$72
LifeScan, Inc.
$60
Antares Pharma, Inc.
$55
ABBVIE INC.
$47
Ultragenyx Pharmaceutical Inc.
$44
IBSA Pharma Inc.
$38
DEXCOM, INC.
$36
IDORSIA PHARMACEUTICALS US INC
$35
Horizon Therapeutics plc
$33
Merck Sharp & Dohme LLC
$33
Mallinckrodt Hospital Products Inc.
$30
AbbVie Inc.
$27
Nestle HealthCare Nutrition Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$24
EUSA Pharma (US) LLC
$24
Merck Sharp & Dohme Corporation
$22
Jazz Pharmaceuticals Inc.
$20
PFIZER INC.
$20
Supernus Pharmaceuticals, Inc.
$19
Mylan Specialty L.P.
$17
Insulet Corporation
$17
AIMMUNE THERAPEUTICS, INC.
$16
Medtronic MiniMed, Inc.
$15
Currax Pharmaceuticals LLC
$15
JAZZ PHARMACEUTICALS INC.
$12
Top 3 companies account for 60.2% of total payments
Associated products mentioned in payments ›
ACTHAR · BAQSIMI · BELSOMRA · BREZTRI · CONTRAVE · Crysvita · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIABETES - DISEASE · DUPIXENT · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · Hillrom - Life 2000 Ventilation System · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · JARDIANCE · Kerendia · Korlym · LEQVIO · LYUMJEV · MINIMED 780G · MOUNJARO · Minimed 670G System · NOCDURNA · NUCALA · ONETOUCH VERIO FLEX · ORENITRAM · Omnia · Omnipod · OneTouch Verio Reflect · Ozempic · Prolastin-C Liquid · QUVIVIQ · Qutenza · RYBELSUS · Repatha · Rybelsus · SIGNIA · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLUJAN · STRENSIQ · SYNTHROID · Senza · Sylvant · TEPEZZA · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TYVASO · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Wegovy · XYOSTED · XYWAV · YUPELRI · ZEGALOGUE · ZENPEP · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (53%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $347 per 100 Medicare services performed
Geographic Context
Endocrinologists within 10 mi
17
Per 100K population
2.1
County median income
$73,099
Nearest hospital
CAPE CORAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Suazo Herrera is a clinical cardiology specialist, with above-average Medicare volume (top 13% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Suazo Herrera experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Suazo Herrera performed 820 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Suazo Herrera receive payments from pharmaceutical companies?
Yes. Dr. Suazo Herrera received a total of $16,145 from 54 companies across 316 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Suazo Herrera's costs compare to other endocrinologists in Cape Coral?
Dr. Suazo Herrera's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Suazo Herrera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Cape Coral
Browse endocrinologists in Cape Coral ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in FL
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in FL
Which FL endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology